血清PCT、IL-1、IL-6在慢性阻塞性肺疾病中的表达及临床意义

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the expression and clinical significance of serum procalcitonin(PCT),interleukin-1(IL-1)and interleukin-6(IL-6)in chronic obstructive pulmonary disease.MethodsFrom January to October in 2016,30 patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)were classified into the AECOPD group,30 patients with stable COPD were selected as the COPD group,and another group of 30 healthy participants for physical examination was selected as the control group in the same period.The indexes of serum PCT,IL-1 and IL-6 were tested and their correlations with pulmonary function were analyzed.ResultsIn the AECOPD group,the levels of serum PCT,IL-1 and IL-6 were significantly higher than those in the COPD group and in the control group,while in comparison of the control group,those in the COPD group were higher,which were both displayed statistical difference(P＜0.05).The level of FEV1%and FEV1/FVC in the AECOPD group was lower compared with those in the COPD group and in the control group,the level of FEV1%and FEV1/FVC in the COPD group was lower than that in the control group,with significant difference(P＜0.05).Expression levels of serum PCT,IL-1 and IL-6 were negatively correlated with FEV1%and FEV1/FVC in pulmonary function,with statistical difference (P＜0.05).ConclusionThe levels of serum PCT,IL-1 and IL-6 in COPD patients are increased with the severity of COPD,and the expression levels are in negative correlations with FEV1%and FEV1/FVC.Detection of the above-mentioned factors can reflect the severity of the COPD and assist on assessing the disease condition and guiding the clinical treatment.

Key words： Chronic obstructive pulmonary disease Procalcitonin Interleukin-1 Interleukin-6 Pulmonary function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU De-hua

Cite this article:

XU De-hua. Expression and clinical significance of serum PCT,IL-1 and IL-6 in chronic obstructive pulmonary disease[J]. 中国当代医药, 2017, 24(20): 30-32.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I20/30

[1]	乔中会，李俊萍.慢性阻塞性肺疾病急性加重期患者死亡原因探讨[J].临床肺科杂志，2012，17（7）：1309-1310.
[2]	曹雯雯，顾玉海，杨阳，等.血清1L-1及1L-8水平在中度海拔地区 COPD 的关系[J].临床肺科杂志，2012，17（9）：1583-1584.
[3]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南年修订版[J].中华结核和呼吸杂志，2014，36（2）：8-17.
[4]	Chen SP，Huang LR，Lu TM，et al.Complementary usage of rhodiola crenulata in chronic obstructive pulmonary disease patients：the effects on cytokines and T cells[J].Phytother Res，2015，29（4）：518-525.
[5]	汤小芳，陈旭娇，柴栖晨，等.老年 COPD 患者 CD4＋、FOXP3＋、PCT、NF-κB 的检测及临床应用[J].中华全科医学，2014，12（2）：241-244.
[6]	李宗莉，丁海菊，张昌红，等.降钙素原对慢性阻塞性肺疾病急性加重患者应用机械通气治疗的预测价值[J].中国当代医药，2015，22（30）：44-46.
[7]	叶枫，钟南山.降钙素原：指导重症细菌感染诊疗的可靠指标[J].中华结核和呼吸杂志，2012，35（11）：873-876.
[8]	张杰，马晋，张颖，等.老年慢性阻塞性肺疾病急性加重期诊断与病情评估中血管内皮因子的应用价值田[J].中国全科医学，2013，16（34）：3317-3320.
[9]	柴燕玲，董昭兴，钟红，等.血清降钙素原水平在慢性阻塞性肺疾病急性加重期优化抗菌治疗中的临床意义[J].昆明医学院学报，2011，32（1）：63-66.
[10]	杜翠霞.血清降钙素原和反应蛋自水平在感染性疾病中的诊断价值[J].实用心脑肺血管病杂志，2012，20（8）：1366-1367.
[11]	王海龙，孙丽蓉.基因多态性与肺动脉高压研究进展[J].临床肺科杂志，2011，16（12）：1928-1930.
[12]	零永军，黄锦浪，吴记平，等.Tfu骨化三醇对类风湿关节炎患者IL-1，IL-6，IFN-γ的抑制作用[J].岭南急诊医学杂志，2015，5（4）：306-307.
[13]	王势涛，倪丹红，王晓元，等.艾拉莫德对类风湿关节炎患者CD3＋T细胞IFN-γ及细饱因子IL-6调节作用的研究[J].中国地方病防治杂志，2015，5（3）：310-312.
[14]	韩利红，张国俊.老年慢性阻塞性肺疾病患者血清细胞因子及细胞免疫的水平及意义[J].中国老年学杂志，2014，34（21）：6065-6066.
[15]	Lacoma A，Prat C，Andreo F，et al.Value of procalcitonin，C-reactive protein，and neopterin in exacerbations of chronic obstructive pulmonary disease[J].lnt J Chron Obstruct Pulm Dis，2011，6（4）：157.
[16]	呼新健，常晓悦.患者血清检测的临床价值及其与肺功能的关系[J].临床肺科杂志，2011，16（9）：1388-1390.